'김갑성' 기자의 전체기사
-
CeraVe Celebrates Two Decades of "Developed with Dermato…
A Global Celebration Unites Dermatologists, Influencers, and Innovators in New York City to Mark 20 Years of the Iconic Skincare Brand NEW YORK, July 23, 2025 -- It's CeraVe-time to celebrate! CeraVe, the global skincare brand recommended by 80,000 dermatologists worldwide1, is celebrating a major milestone: 20 years of skin barrier authority, championing barrier health and delivering effective, skin identical ceramide and MVE solutions to provide accessible, therapeutic skincare solutions for everybody everywhere. Over the past two decades, CeraVe has catapulted from a
- 김갑성 기자
- 2025-07-23 20:35
-
'피부과 전문의 개발' 스킨케어 브랜드 세라비, 20년 간의 피부 장벽 과학과 혁신 성과 기념
전 세계 피부과 전문의, 인플루언서, 혁신가들이 뉴욕에 모여 상징적인 스킨케어 브랜드의 20주년을 기념 뉴욕, 2025년 7월 23일 -- 세라비(CeraVe)의 시간을 축하할 때다. 전 세계 8만 명 이상의 피부과 전문의가 추천1하는 글로벌 스킨케어 브랜드 세라비가 피부장벽 전문 브랜드로서의 20년 여정을 기념하는 뜻깊은 이정표를 맞았다. 세라비는 그동안 피부장벽 건강의 중요성을 알리고, 피부 동일 세라마이드와 MVE를 활용한 효과적인 솔루션을 통해 모든 사람에게 접근 가능한 치료 기반 스킨케어를 제공해 왔다. 지난 20년 동안 세라비는 미국 내 피부과 전문의들만이 추천하는 비밀 브랜드에서 전 세계적인 현상으로 자리매김하며, 성별과 세대를 초월한 포용적 브랜드로 성장했다. 그 중심에는 변하지 않는 브랜드 인사이트가 있다. 대부분의 피부 문제는 피부 장벽 손상과 관련이 있으며, 이를 회복하고 유지하기 위해서는 피부 동일 세라마이드가 핵심이다. 이러한 인사이트는 세 가지 핵심 제품(모이스처라이징 크림, 모이스처라이징 로션, 하이드레이팅 클렌저)으로 출발해, 현재 90개 이상의 피부 장벽 강화 제품으로 확장해 글로벌 포트
- 김갑성 기자
- 2025-07-23 20:35
-
Health In Tech Donates 60 Computers to Diocese of Srikakula…
STUART, Fla., July 23, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce its donation of 60 new computers to the Diocese of Srikakulam, furthering educational opportunities and digital inclusion for children and families across the region. This contribution reflects Health In Tech's commitment to creating positive community impact that extends beyond health insurance and technology solutions. "The Diocese of Srikakulam deeply appreciates this generous gift from Health In Tech,"
- 김갑성 기자
- 2025-07-23 18:30
-
Elevating Care: GuidelineX Showcases AI-Powered Clinical D…
KUALA LUMPUR, Malaysia, July 23, 2025 -- At the HIMSS APAC 2025 conference, GuidelineX made a powerful impact with its next-generation, AI-native Clinical Decision Support System (AI-CDSS). In her keynote, "Empowering Clinicians and Elevating Care: AI-Based Clinical Decision Support Systems," Chief Medical Officer Dr. Jenny Shao captured the attention of healthcare leaders and policymakers across the region. Dr. Shao addressed the limitations of traditional technologies in solving healthcare's biggest challenges—rising costs, resource shortages, and increasing demands
- 김갑성 기자
- 2025-07-23 18:00
-
Global Dental Leaders to Convene in Shanghai for FDI World…
SHANGHAI, July 23, 2025 -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will take place in Shanghai, China, from September 9–12, 2025, co-hosted by Chinese Stomatological Association and Reed Sinopharm Exhibitions. Organized annually in different countries, the WDC highlights the importance of oral health in securing overall health and well-being and serves as a driving force for international collaboration in dentistry. In recent years, visa-free policies have made China an increasingly popular destination for global t
- 김갑성 기자
- 2025-07-23 17:53
-
Singapore-Based Innovative Biomedical Start-Up Achieves 'S…
[ 메디채널 김갑성 기자 ] NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China is the largest and most important success in the company's history; product approval in China was the company's most important strategic and operational goal Syntellix had previously already been granted the accelerated 'innovative pathway' by the NMPA due to the exceptional benefits of its products In total, product approvals for Syntellix products have accumulated to date in countries with more than 5.5 billion
- 김갑성 기자
- 2025-07-23 15:35
-
Landmark Trial Demonstrates Efficacy of Microcurrent Therap…
ZUG, Switzerland, July 23, 2025 -- Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II trial results in the European Journal of Heart Failure. The study, titled "Cardio-microcurrent Device Treatment for Heart Failure with Reduced Ejection Fraction: Results from the C-MIC II Open Label Randomized Controlled Trial," was previously presented as a Late-Breaking Clinical Trial (LBCT) at the 2025 ESC-HFA Congress in Belgrade. The findings mark a major advancement in the field of bioelectronic medicine for heart failure, highl
- 김갑성 기자
- 2025-07-23 15:00
-
Zylox-Tonbridge Issues Positive Profit Alert, Expects Over RMB 1…
HANGZHOU, China, July 23, 2025 -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company"), a leading medical device company in China's peripheral and neurovascular interventional market, today announced a positive profit alert for the six months ended June 30, 2025. Based on preliminary unaudited figures, the Company expects to record revenue of over RMB 480 million, representing a year-on-year increase of approximately 31.1%. Net profit is anticipated to exceed RMB 115 million, reflecting a robust growth of approximately 66.9% compare
- 김갑성 기자
- 2025-07-23 14:57
-
Samsung Biologics reports second quarter 2025 financial re…
Recorded Q2'25 consolidated revenue of KRW 1,289.9 billion Recorded Q2'25 consolidated operating profit of KRW 475.6 billion Solid momentum sustained through capacity ramp-up and stable project execution INCHEON, South Korea, July 23, 2025 -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced its financial results for the second quarter of fiscal year 2025. "Our second quarter results demonstrate continued strong momentum across our business," said John Rim, CEO and Pr
- 김갑성 기자
- 2025-07-23 14:54
-
HIMSS APAC 2025: Malaysian Health Minister Visits GuidelineX Exh…
KUALA LUMPUR, Malaysia, July 22, 2025 -- Dr. Dzulkefly Ahmad, Minister of Health of Malaysia, visited the GuidelineX exhibition at HIMSS APAC 2025, where he engaged in comprehensive discussions on AI-powered clinical decision support systems (CDSS). The minister examined the practical applications of GuidelineX's technology, which has supported 61 million inpatient visits and facilitated 1.4 billion outpatient visits annually across China, representing 25% and 33% of the national patient visits to hospitals, respectively. Dr. Ahmad noted Malaysia's ongoing efforts in digital health and
- 김갑성 기자
- 2025-07-22 22:20
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-20_MON
- CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025 08:15
- Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity 08:10
- ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) 08:10
- Leading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group 07:25
- Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances 07:00
- Webull Reduces Minimum ASX Trading Fee To $1 06:00
- Yaber Expands Its Global Footprint -- Now Available at JB Hi-Fi Across Australia 05:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 20일 09시 40분